G Guru DNA Investor Style
Q3 2025 · 13F
GURU PROFILE · Q3 2025 · 13F-HR Standard
BB

Brian Bares — concentrated balanced

Brian Bares runs Bares Capital Management with a concentrated approach to high-conviction businesses. The book is concentrated with a high contrarian reading and low quality scores.

Bares Capital Management
Positions
24
Avg Annual Return, 5 yr
−7,0%
Alpha vs S&P 500, Annual
−25,5%
Max Drawdown
−27,7%
Sharpe (5 yr)
−0,13

DNA Fingerprint

6 axes · Q3 2025
255075100VALUE60RISK86CONCENTRATION71TURNOVER34QUALITY24CONTRARIAN66
Q3 2025 (latest)

Style Traits

  • Value Value / Growth
    60 +7 since Q3 2024

    Growth Value

  • Risk Risk Appetite
    86 −1 since Q3 2024

    Low High

  • Concentration Portfolio Focus
    71 −8 since Q3 2024

    Diversified Focused

  • Turnover Trading Activity
    34 −58 since Q3 2024

    Long-term Active

  • Quality Profitability
    24 +2 since Q3 2024

    Speculative Profitable

  • Contrarian Contrarianism
    66 +21 since Q3 2024

    With Crowd Against Crowd

Methodology

Each axis is a percentile rank from 0 to 100 relative to the profiled guru cohort; 50 is the cohort midpoint. The higher the value, the stronger the trait. The dashed overlay is the median shape of the guru's behavioral peer group, so you can read where this investor is unusual within their own style. The Trajectory arrows trace the drift from four quarters ago to now — an illustration of the method over a short window, not a statistical claim.

  • Value (Value / Growth) — how cheaply the portfolio's stocks are priced versus the market, by valuation multiples (e.g. price-to-earnings). A higher score means cheaper, value-style picks; a lower score means pricier, growth-style bets the market expects to grow fast.
  • Risk (Risk Appetite) — how much price volatility and business fragility the portfolio carries. A higher score means bolder, more volatile holdings (think biotech or meme stocks); a lower score means defensive, steady names like utilities and staples.
  • Concentration (Portfolio Focus) — how much of the portfolio sits in its few largest positions. A higher score means a focused book of big convictions; a lower score means bets spread thinly across many names.
  • Turnover (Trading Activity) — how much the lineup of holdings changes from one quarter to the next. A higher score means an active trader rotating names in and out; a lower score means a patient, buy-and-hold roster.
  • Quality (Profitability) — how profitable and financially solid the businesses in the portfolio are. A higher score means durable, profitable companies; a lower score means speculative or pre-profit bets.
  • Contrarian (Contrarianism) — how often the guru's trades go against what the other gurus are doing. A higher score means buying what the crowd sells and vice versa; a lower score means moving with the consensus.

Extended DNA

Beyond the radar's six: two further behavioral reads — whether new buys add to existing holdings or start fresh, and the size of companies the book favors — on the same 0–100 cohort-percentile scale.

  • Follow-On Buying — Of the quarter's buys, the share that add to tickers already held rather than open fresh positions. A higher score means doubling down on existing convictions; a lower score means spreading into new bets.
  • Size Bias — Whether the book tilts toward large, easy-to-trade companies or smaller, thinly-traded ones — gauged from each holding's trading liquidity, which stands in for company size rather than measuring market cap directly. A higher score means large, liquid mega-caps; a lower score means smaller, less-liquid names.
  • Conviction Follow-On Buying
    49 +39 since Q3 2024

    New bets Adds to conviction

  • Size Size Bias
    36 −39 since Q3 2024

    Small-cap Large-cap

DNA Anomalies

style stable · basis Q1 2024–Q2 2025
GURU PATTERNBOUGHT · LARGERSOLD · LARGERSOLD · SMALLERBOUGHT · SMALLERsoldboughtlargersmaller
Dot colour — type of deviationConcentration / contrarianMomentumOther positions (no deviation)5% of portfolio
What deviated from pattern

Style is stable — no significant deviations from pattern.

Backtest · Cost of Delay

real 13F delay vs S&P 500
Cost of Delay

Copying with the real 13F publication delay earns an extra  1,5 pp of return over 2 years.

Guru (2 years)
−14,6%
Copier (13F)
−13,2%
S&P 500
+44,6%
70901101301508587145Q2 ’24Q3 ’24Q4 ’24Q1 ’25Q2 ’25Q3 ’25Q4 ’25Q1 ’26Q2 ’26DELAY SPREAD

Managers with assets above $100M disclose positions in Form 13F-HR within 45 days after quarter end. The backtest runs three $100,000 portfolios: the guru rebalances at quarter-end prices, the copier mirrors the same weights on the actual filing date, and S&P 500 is the benchmark.

The hatched area is the cost of delay: the difference in cumulative returns between the guru and the copier in percentage points. The delay is not always a disadvantage — if a stock fell between quarter end and the filing date, the copier buys in cheaper.

The guru curve is also a model: 13F shows only long positions in US equities at quarter end, without intra-quarter trades, shorts, or cash. Commissions, slippage, and taxes are not accounted for.

Notable Signals

synthesis metrics
Single-name conviction
PEGA

Pegasystems Inc. anchors the book at 17.9%

A 17.9% weight in a single name — concentration that makes PEGA the book's center of gravity.

Conviction
Concentration × Turnover

Buy-and-hold conviction

Concentrated and low-turnover — large positions held with patience (concentration 71/100, turnover 34/100 vs peers).

Conviction
Risk × Quality

Swinging for the fences

High risk appetite with low quality scores — the boom-or-bust end of the cohort (risk 86/100, quality 24/100 vs peers).

Aggressive

Top 10 Positions

of 24 · Q3 2025
Ticker Company Δ for quarter Weight
PEGA Pegasystems Inc. −0,8
17,9%
SQ Block, Inc. −0,9
13,2%
WDAY Workday, Inc. +0,7
13,2%
IBKR Interactive Brokers Group, Inc. −3,1
13,1%
CSGP CoStar Group, Inc. +0,1
9,6%
ETSY Etsy, Inc. +1,7
8,7%
ALGN Align Technology, Inc. −2,5
7,0%
W Wayfair Inc. +1,8
5,5%
MEDP Medpace Holdings, Inc. +0,5
5,3%
GMED Globus Medical, Inc. +2,8
2,8%